Lakefront Biotherapeutics (LKFT) Amortizatization of Intangibles (2016 - 2018)

Lakefront Biotherapeutics (LKFT) has reported Amortizatization of Intangibles for 3 consecutive years, with -$2.6 billion the latest figure, recorded in Q3 2018.

• Quarterly Amortizatization of Intangibles fell 399.61% year-over-year to -$2.6 billion in Q3 2018, while the trailing twelve-month figure through Sep 2018 was -$521.9 million (down 49773.08% YoY) and the FY2017 annual result came in at $940972.7, down 24.19% from the prior year.
• Amortizatization of Intangibles retreated to -$2.6 billion in Q3 2018 per LKFT's latest filing, from $2.6 billion in the prior quarter.
• Over the last five years, Amortizatization of Intangibles for LKFT reached as high as $2.6 billion in Q2 2018 and fell as low as -$2.6 billion in Q3 2018.
• A 3-year average of $506386.2 and a median of $280704.3 in 2016 frame the typical range for Amortizatization of Intangibles.
• Annual changes were most pronounced in 2017 — Amortizatization of Intangibles jumped 166789.91% — and 2018, when it tumbled 399.61%.
• Year by year, Amortizatization of Intangibles stood at $314619.7 in 2016, then fell by 17.43% to $259777.7 in 2017, then slumped by 1009003.89% to -$2.6 billion in 2018.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered -$2.6 billion, $2.6 billion, and $259777.7 for Q3 2018, Q2 2018, and Q4 2017 respectively.